Inmune Bio Inc (INMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 16 | 163 | 163 | 14 | 0 |
| Gross Profit | 16 | 163 | 163 | 14 | N/A |
| Operating Expenses | 6,404 | 6,641 | 9,193 | 9,035 | 6,554 |
| Operating Income | -6,388 | -6,478 | -9,030 | -9,021 | -6,554 |
| Other Income | -450 | -425 | -641 | -437 | -101 |
| Pre-tax Income | -6,838 | -6,903 | -9,671 | -9,458 | -6,655 |
| Net Income Continuous | -6,838 | -6,903 | -9,671 | -9,458 | -6,655 |
| Net Income | $-6,838 | $-6,903 | $-9,671 | $-9,458 | $-6,655 |
| EPS Basic Total Ops | -0.38 | -0.39 | -0.57 | -0.55 | -0.44 |
| EPS Basic Continuous Ops | -0.38 | -0.39 | -0.57 | -0.55 | -0.44 |
| EPS Diluted Total Ops | -0.38 | -0.39 | -0.57 | -0.55 | -0.44 |
| EPS Diluted Continuous Ops | -0.38 | -0.39 | -0.57 | -0.55 | -0.44 |
| EBITDA(a) | $-6,331 | $-6,422 | $-8,973 | $-8,968 | $-6,554 |